# Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

> **NCT00351052** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 184 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Pimecrolimus
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00351052
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** —
- **Final completion:** 2004-09
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2008-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351052, "Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00351052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*